Company filings profile · CIK 0001789972

Cullinan Therapeutics, Inc. — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for Cullinan Therapeutics, Inc. (CGEM): 15 filings in the last 90 days vs 21 in the prior 90 (filing-velocity cooling ↓ · 0.71×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Oct 2, 2026. Source-linked, daily-refreshed.

Material 8-K events — Cullinan Therapeutics, Inc.

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
Oct 2, 2026Regulation FD Disclosure; Other Events; Financial Statements and Exhibits↗
Sep 24, 2026Regulation FD Disclosure; Other Events; Financial Statements and Exhibits↗
Sep 14, 2026Regulation FD Disclosure; Other Events; Financial Statements and Exhibits↗
Aug 13, 2026Regulation FD Disclosure; Other Events; Financial Statements and Exhibits↗
Aug 6, 2026Results of Operations (earnings); Financial Statements and Exhibits↗
Jun 16, 2026Item 5.07↗
Jun 10, 2026Regulation FD Disclosure; Other Events; Financial Statements and Exhibits↗
Jun 8, 2026Regulation FD Disclosure; Other Events; Financial Statements and Exhibits↗
May 18, 2026Regulation FD Disclosure; Other Events; Financial Statements and Exhibits↗
May 7, 2026Results of Operations (earnings); Financial Statements and Exhibits↗
Mar 10, 2026Results of Operations (earnings); Financial Statements and Exhibits↗

Watch Cullinan Therapeutics, Inc. automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Insider transactions (Form 4 / 3 / 5)

FiledForm
Sep 10, 20264↗
Aug 14, 20264↗
Jul 7, 20264↗
Jul 2, 20264↗
Jul 2, 20264↗
Jun 18, 20264↗
Jun 18, 20264↗
Jun 18, 20264↗
Jun 18, 20264↗
Jun 18, 20264↗
Jun 18, 20264↗
May 6, 20264↗
Mar 9, 20264↗
Feb 26, 20264↗
Feb 25, 20264↗
Feb 25, 20264↗
Feb 25, 20264↗
Feb 25, 20264↗
Feb 23, 20264↗
Feb 23, 20264↗

Recent filings

FiledFormDetail
Oct 2, 20268-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits ↗
Sep 24, 20268-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits ↗
Sep 14, 20268-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits ↗
Sep 10, 20264 4 ↗
Sep 8, 2026144 ↗
Aug 14, 20264 4 ↗
Aug 14, 2026SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G ↗
Aug 13, 2026144 ↗
Aug 13, 20268-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits ↗
Aug 7, 2026SCHEDULE 13G ↗
Aug 6, 202610-Q 10-Q ↗
Aug 6, 20268-K Results of Operations (earnings); Financial Statements and Exhibits ↗
Jul 7, 20264 4 ↗
Jul 6, 2026144 ↗
Jul 2, 20264 4 ↗
Jul 2, 20264 4 ↗
Jun 18, 20264 4 ↗
Jun 18, 20264 4 ↗
Jun 18, 20264 4 ↗
Jun 18, 20264 4 ↗
Jun 18, 20264 4 ↗
Jun 18, 20264 4 ↗
Jun 16, 20268-K Item 5.07 ↗
Jun 10, 20268-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits ↗
Jun 8, 20268-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits ↗
May 18, 20268-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits ↗
May 15, 2026SCHEDULE 13G/A ↗
May 7, 202610-Q 10-Q ↗
May 7, 20268-K Results of Operations (earnings); Financial Statements and Exhibits ↗
May 6, 20264 4 ↗
May 5, 2026144 ↗
Apr 28, 2026S-3ASR S-3ASR ↗
Apr 28, 2026DEFA14A DEFA14A ↗
Apr 28, 2026DEF 14A DEF 14A ↗
Apr 28, 2026ARS ARS ↗
Mar 26, 2026SCHEDULE 13G/A ↗
Mar 10, 2026S-8 S-8 ↗
Mar 10, 202610-K 10-K ↗
Mar 10, 20268-K Results of Operations (earnings); Financial Statements and Exhibits ↗